A delegation from the Indian Pharmacopoeia Commission (IPC), Ministry of Health & Family Welfare, Government of India, led by Dr. V. Kalaiselvan, Secretary-cum-Scientific Director, along with Dr. Pawan Saini and Dr. Shruti Rastogi, participated in the 16th International Meeting of World Pharmacopoeias (IMWP) and the accompanying Stakeholders’ Meeting held in Brasília, Brazil, from 15^th to 17^th June 2026.

The meeting, coordinated by the World Health Organization (WHO), brought together representatives from leading pharmacopoeias worldwide, including the Brazilian Pharmacopoeia (Brazil), European Pharmacopoeia (Europe), Indian Pharmacopoeia (India), Japanese Pharmacopoeia (Japan), Korean Pharmacopoeia (Republic of Korea), Mexican Pharmacopoeia (Mexico), Russian Pharmacopoeia (Russian Federation), British Pharmacopoeia (United Kingdom), United States Pharmacopeia (United States of America), State Pharmacopoeia of the Republic of Uzbekistan (Uzbekistan), Vietnamese Pharmacopoeia (Vietnam) and The International Pharmacopoeia of WHO.

During the meeting, Dr. Kalaiselvan presented key updates on the Indian Pharmacopoeia, highlighting recent advancements in pharmacopoeial standards, modernization initiatives, and India's contributions towards global harmonization of medicine quality standards. Discussions during the meeting reaffirmed that the standards of the Indian Pharmacopoeia are comparable with leading international pharmacopoeias. India was also recognized for its leadership in developing and establishing quality standards for anti-tuberculosis medicines, anti-cancer therapeutics, blood and blood products, medicines used in the management of anaemia, and other complex pharmaceutical molecules, reflecting the country's growing scientific, regulatory, and pharmacopoeial capabilities.

The Indian delegation actively contributed to discussions on modern microbiological methods, pharmacopoeial convergence, and environmental sustainability in pharmaceutical standards. At the Stakeholders’ Meeting, Dr. Kalaiselvan, showcased its role in strengthening public health through science-based standards and regulatory support, while emphasizing the importance of international cooperation in ensuring the quality, safety, and efficacy of medicines worldwide. India’s participation at the 16^th IMWP further strengthened collaboration with international pharmacopoeias and reaffirmed the country’s growing leadership in shaping global pharmaceutical quality standards for the benefit of patients worldwide.

*****

SR

HFW/IPC at 16^th International Meeting of World Pharmacopoeias/18June 2026/1

(रिलीज़ आईडी: 2274525) आगंतुक पटल : 509